SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 83.09 |
| Enterprise Value ($M) | 57.25 |
| Book Value ($M) | -99.23 |
| Book Value / Share | -0.82 |
| Price / Book | -0.84 |
| NCAV ($M) | -162.87 |
| NCAV / Share | -1.35 |
| Price / NCAV | -0.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.91 |
| Return on Equity (ROE) | -4.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.65 |
| Current Ratio | 0.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 101.87 |
| Assets | 165.50 |
| Liabilities | 264.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 8.57 |
| Operating Income | -269.28 |
| Net Income | -276.13 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -192.98 |
| Cash from Investing | 123.87 |
| Cash from Financing | 2.01 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Citadel Advisors Llc | 6.40 | ||
| 13G/A | Maverick Capital Ltd | 0.00 | -100.00 | |
| 13G/A | Redmile Group, LLC | 9.90 | 4.72 | |
| 13G/A | Vanguard Group Inc | 6.56 | -7.28 | |
| 13G/A | Wasatch Advisors Inc | |||
| 13G/A | Goldman Sachs Group Inc | 0.60 | -90.49 | |
| 13G/A | BlackRock Inc. | 7.00 | -22.56 | |
| 13G/A | State Street Corp | 2.73 | -63.60 | |
| 13G/A | Baupost Group Llc/ma | 0.00 | -100.00 | |
| 13G/A | Jpmorgan Chase & Co | 2.10 | -70.62 | |
| 13G | EcoR1 Capital, LLC | 9.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 224,885 | 1,117,460 | 20.12 | |
| 158,367 | 196,572 | 80.56 | |
| 204,684 | 183,673 | 111.44 | |
| 76,426 | 118,667 | 64.40 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ARWR – Arrowhead Pharmaceuticals, Inc. | ASMB – Assembly Biosciences, Inc. |
| ATHA – Athira Pharma, Inc. | AVIR – Atea Pharmaceuticals, Inc. |
| AVRO – AVROBIO, Inc. |
Financial data and stock pages provided by
Fintel.io